Abstracts tagged "Juvenile SLE and morbidity and mortality"

Abstract Number: 2648 • 2018 ACR/ARHP Annual Meeting
Relationship between Damage and Mortality in Juvenile-Onset Systemic Lupus Erythematosus: Cluster Analyses in a Large Cohort from the Spanish Society of Rheumatology Lupus Registry
JM Pego-Reigosa¹, TC Salman-Monte², Irene Altabás-González³, Iñigo Rúa-Figueroa⁴, Jacobo de Uña⁵, V Balboa-Barreiro⁶, Francisco Javier López Longo⁷, María Galindo⁸, Jaime Calvo-Alen⁹, Alejandro Olivé-Marqués¹⁰, Coral Mouriño-Rodriguez¹¹, Eva Tomero¹², Maria Loreto Horcada¹³, Ana Sánchez Atrio¹⁴, Carlos Alberto Montilla-Morales¹⁵, Eva Salgado¹⁶, Elvira Diez Alvarez¹⁷, Ricardo Blanco¹⁸, Jose Luis Andreu¹⁹, O Fernández-Berrizbeitia²⁰, José Hernández Beiraín²¹, Marian Gantes²², Blanca Hernández-Cruz²³, Angela Pecondon-Español²⁴, Carlos Marras Fernandez-Cid²⁵, María Gema Bonilla Hernán²⁶, Jesús García-Villanueva²⁷ and Vicente Torrente²⁸, ¹Complexo Hospitalario Universitario de Vigo, Vigo, Spain, ²Rheumatology, Hospital del Mar/Parc de Salut Mar, Barcelona, Spain, ³Rheumatology, Hospital Doctor Negrin, Las Palmas GC, Spain, ⁴Rheumatology Division, Hospital Doctor Negrin, Las Palmas GC, Spain, ⁵Statistics and OR, Vigo University, Vigo, Spain, ⁶Department of Statistics and OR, Vigo University, Vigo (Spain), Vigo, Spain, ⁷Rheumatology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain, ⁸Servicio de Reumatología, Hospital 12 de Octubre, Madrid, Spain, ⁹Rheumatology, Txagorritxu Hospital, Araba, Vitoria, Vitoria, Spain, ¹⁰Rheumatology, Hospital Universitari Germans Trias i Pujol, Badalona, Spain, ¹¹Rheumatology, Rheumatology Section, Complexo Hospitalario Universitario de Vigo, Pontevedra, Spain, Vigo, Spain, ¹²Rheumatology, Hospital de La Princesa. Madrid. Spain, Madrid, Spain, ¹³Rheumatology, Hospital de Navarra, Pamplona, Spain, ¹⁴University Hospital Príncipe de Asturias, Immune System Diseases, Rheumatology Department, Alcalá de Henares, Madrid, Spain, ¹⁵Hospital Clínico Universitario de Salamanca. Spain, Salamanca, Spain, ¹⁶RheumatologyDepartment, Hospital Complex of Ourense, Ourense (Spain), Ourense, Spain, ¹⁷Complejo Asistencial Universitario de León, León, Spain, ¹⁸Rheumatology Department,, Hospital Marqués de Valdecilla, Santander, Spain, ¹⁹Rheumatology, Hospital Universitario Puerta de Hierro Majadahonda, Madrid, Spain, ²⁰Rheumatology Department Basurto Hospital, País Vasco, Basurto (Spain), Bilbao, Spain, ²¹Rheumatology, Hospital Insular de Gran Canaria, Las palmas Gran Canarias, Spain, ²²Rheumatology, Hospital Universitario de Canarias, La Laguna; Tenerife, Spain, ²³Rheumatology, Hospital Universitario Virgen Macarena, Sevilla, Spain, ²⁴Rheumatology, Hospital Miguel Servet, Zaragoza, Spain, ²⁵Rheumatology, Hospital Virgen de la Arrixaca, Murcia, Spain, ²⁶Rheumatology Department, Hospital Universitario La Paz, IdiPAZ, Madrid, Spain, ²⁷HOSPITAL RAMÓN Y CAJAL, Madrid, Spain, ²⁸Hospital de dia Baix de LLobregat, LLobregat, Spain
Background/Purpose: To identify patterns (clusters) of damage manifestation within a large cohort of juvenile SLE (jSLE) patients and evaluate their possible association with mortality. Methods:…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].